BLACK WEEKSFlakoni −15% · komplekti −10% · pārējais −5%ar koduBezmaksas piegāde Vācijā no €200

Šī lapa ir tulkota automātiski un var saturēt kļūdas. Vai latviešu valoda ir jūsu dzimtā valoda? Mēs labprāt saņemsim jūsu atsauksmes un labojumus.Sūtīt atsauksmi

The Peptide Desk The Peptide Desk
SS-31, produkta foto

2 laboratorijas ziņojumi

PDF
99%
Tīrība
Pārbaudīts
SS-31 10mg
Laboratorija
Analiza Białek
Datums
November 2026
Rezultāts
99% purity (10.99 mg measured)
Endotoksīni
4.82 EU/vial
Pasūtījuma nr.
Parole

Neatkarīgi pārbaudīts, ar paroli pārbaudāms tieši laboratorijā.

Anti-Aging

SS-31

Anti-Aging

Pasūtījums

Vienības cena - Bezmaksas piegāde Vācijā no 200 € Black Weeks laikā
  • DHL ar izsekošanu
  • Diskrēts iepakojums

4.6 no 5 Trustpilot73 atsauksmes

Īsumā

SS-31 skaitļos

Galvenie rādītāji no mūsu leksikona.

Pilns leksikona ieraksts
Class
Mitochondria-targeted peptide
Half-life
short
Use
Subcutaneousin mg
Sizes
10 to 50 mg2 sizes in the shop

Zināšanas

Viss par SS-31

Noderēs

Kas jums vēl būs vajadzīgs

Bakteriostatiskais ūdens tiek automātiski pievienots grozam. Šļirces un salvetes - ar vienu klikšķi.

Insulīna šļirces

10 gab. · 5.50 €

Spirta salvetes

50 gab. · 10 €

Cik daudz ūdens?

Vienības uz šļirces jūsu flakona izmēram.

Atvērt kalkulatoru →

FAQ

Bieži uzdotie jautājumi

Avoti katrai atbildei: leksikona ieraksts

Vēl ir jautājums?

Rakstiet mums, mūsu komanda jums palīdzēs.

Is SS-31 approved?

In the USA yes, but narrowly: since September 2025 there is an accelerated approval for Barth syndrome in people weighing at least 30 kg. It rests on more strength in the knee extensor muscle, full approval depends on a confirmatory trial that is currently recruiting according to the registry. Elamipretide is not listed in the medicines data of the European Medicines Agency (as of 25 October 2026).

How does SS-31 work?

SS-31 binds cardiolipin, a lipid of the inner mitochondrial membrane that shapes the cristae. In cell assays the peptide family SS-31 belongs to concentrated about 1,000-fold in this membrane. In animal models SS-31 protected the cristae during oxygen shortage, curbed a harmful reaction of cytochrome c and the cell rebuilt ATP faster afterwards.

What did research in mitochondrial myopathy show?

In the first trial (5 days of infusion, 36 participants) people at the highest study dose walked 64.5 m further on average in the 6-minute walk test, 20.4 m on placebo. The crossover trial with 30 people saw a 19.8 m difference, not statistically significant, but less fatigue. The phase 3 trial with 218 people over 24 weeks found no difference: minus 3.2 m versus placebo.

What came out in Barth syndrome?

In the crossover trial with 12 people (12 weeks each on the compound and on placebo) neither primary endpoint was met. In the open-label extension without placebo walking distance rose: by 95.9 m after 36 weeks and by 96.1 m in total after 168 weeks in the 8 remaining people. Fatigue was below baseline at every time point.

And for heart and eye?

In heart failure a single high infusion reduced the heart chamber volumes (minus 18 ml end-diastolic versus placebo), after 4 weeks of daily dosing there was no difference in 71 people. In heart attack the infarct did not get smaller. In dry macular degeneration the phase 2 trial missed its primary endpoints, but the photoreceptor layer was lost 43 to 47% more slowly. A phase 3 trial on this runs until 2027.

Which side effects were seen?

Most often injection-site reactions such as redness, pain, itching and induration, mostly mild. In the myopathy crossover trial 80% had such reactions. In trials of 30 days or longer eosinophils in the blood often rose and fell back after 6 to 12 months or after stopping. In the eye trial 86% on the compound and 71% on placebo reported some adverse event.

How long does SS-31 stay in the body?

Only briefly. Injected under the skin the level peaks after 0.5 to 1 hour, about 92% reaches the blood. SS-31 is broken down step by step into inactive fragments and almost completely excreted in the urine within 48 hours. After a single infusion it was no longer detectable 24 hours later. That is why the trials gave it daily.

Saistītie

Saistītie produkti